Researchers at the Korea Institute of Toxicology and Ajou University have developed a nanobiosensor that can detect antibodies in serum with high ion concentrations. The team said the platform produced clear electrical signals in a physiological solution and in human serum when target antibodies bound to the sensor. The result addresses a central limitation of conventional carbon-nanotube field-effect transistor sensors, whose signals can weaken in body fluids.
The difficulty comes from the dense ionic environment of serum. Ions can screen the electrical charge of biological molecules, reducing the signal that reaches a sensor. Instead of trying to eliminate that interference, the researchers measured electrical changes at a Schottky junction formed between a single-walled carbon-nanotube thin film and a gold electrode. Binding at the electrode interface changed the current, creating the detectable response.
The tests used a solution with an ionic strength of about 150 millimolar, similar to physiological conditions, as well as actual human serum. The researchers said the sensor surface can be modified with different recognition materials, allowing the platform to target toxic proteins or antigens and antibodies associated with infectious diseases. The reported work demonstrates laboratory detection in challenging samples, but it does not establish clinical performance or commercial availability.
The team plans to connect the technology with organoids and three-dimensional cell cultures. That work is intended to support real-time measurement of cellular and tissue responses to drugs and environmentally harmful substances. The study was supported by the Korea Institute of Toxicology and the National Research Foundation of Korea and was published in Biosensors and Bioelectronics.
